REFERENCES
- Jemal , A , Siegel , R , Ward , E , Murray , T Xu , J . 2006 . Cancer statistics, 2006 . CA Cancer J Clin , 56 : 106 – 130 .
- Ries , L AG , Harkins , D , Krapcho , M , Mariotto , A Miller , B A . SEER Cancer Statistics Review, 1975–2004 http://seer.cancer.gov.csr/1975_2004/ Accessed August 24, 2007
- Blair , A . 2007 . Cancer and the Environment-NCI http://www.cancer.gov/newscenter/benchmarks-vol14-issue3/page1 Accessed August 24, 2007
- Divisi , D , Di Tommaso , S , Salvemini , S , Garramone , M and Crisci , R . 2006 . Diet and cancer . Acta Biomed , 77 : 118 – 123 .
- Gonzalez , C A . 2006 . Nutrition and cancer: the current epidemiological evidence . Br J Nutr , 96 ( Suppl 1 ) : S42 – S45 .
- Giovannucci , E . 2005 . Tomato products, lycopene, and prostate cancer: a review of the epidemiological literature . J Nutr , 135 : 2030S – 2031S .
- Giovannucci , E , Rimm , E B , Liu , Y , Stampfer , M J and Willett , W C . 2002 . A prospective study of tomato products, lycopene, and prostate cancer risk . J Natl Cancer Inst , 94 : 391 – 398 .
- Giovannucci , E , Rimm , E B , Liu , Y , Stampfer , M J and Willett , W C . 2003 . A prospective study of cruciferous vegetables and prostate cancer . Cancer Epidemiol Biomarkers Prev , 12 : 1403 – 1409 .
- Fleshner , N E and Kucuk , O . 2001 . Antioxidant dietary supplements: rationale and current status as chemopreventive agents for prostate cancer . Urology , 57 : 90 – 94 .
- Ripple , M O , Henry , W F , Rago , R P and Wilding , G . 1997 . Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells . J Natl Cancer Inst , 89 : 40 – 48 .
- Sun , X Y , Donald , S P and Phang , J M . 2001 . Testosterone and prostate specific antigen stimulate generation of reactive oxygen species in prostate cancer cells . Carcinogenesis , 22 : 1775 – 1780 .
- Hirschhorn , J N , Lohmueller , K , Byrne , E and Hirschhorn , K . 2002 . A comprehensive review of genetic association studies . Genet Med , 4 : 45 – 61 .
- Kaput , J and Rodriguez , R L . 2004 . Nutritional genomics: the next frontier in the postgenomic era . Physiol Genomics , 16 : 166 – 177 .
- Wispe , J R , Clark , J C , Burhans , M S , Kropp , K E Korfhagen , T R . 1989 . Synthesis and processing of the precursor for human mangano-superoxide dismutase . Biochim Biophys Acta , 994 : 30 – 36 .
- Chance , B , Sies , H and Boveris , A . 1979 . Hydroperoxide metabolism in mammalian organs . Physiol Rev , 59 : 527 – 605 .
- Costello , L C and Franklin , R B . 2000 . The intermediary metabolism of the prostate: a key to understanding the pathogenesis and progression of prostate malignancy . Oncology , 59 : 269 – 282 .
- Li , N , Oberley , T D , Oberley , L W and Zhong , W . 1998 . Overexpression of manganese superoxide dismutase in DU145 human prostate carcinoma cells has multiple effects on cell phenotype . Prostate , 35 : 221 – 233 .
- Li , J J , Oberley , L W , St Clair , D K , Ridnour , L A and Oberley , T D . 1995 . Phenotypic changes induced in human breast cancer cells by overexpression of manganese-containing superoxide dismutase . Oncogene , 10 : 1989 – 2000 .
- Church , S L , Grant , J W , Ridnour , L A , Oberley , L W Swanson , P E . 1993 . Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells . Proc Natl Acad Sci U S A , 90 : 3113 – 3117 .
- Liu , R , Oberley , T D and Oberley , L W . 1997 . Transfection and expression of MnSOD cDNA decreases tumor malignancy of human oral squamous carcinoma SCC-25 cells . Hum Gene Ther , 8 : 585 – 595 .
- Yan , T , Oberley , L W , Zhong , W and St Clair , D K . 1996 . Manganese-containing superoxide dismutase overexpression causes phenotypic reversion in SV40-transformed human lung fibroblasts . Cancer Res , 56 : 2864 – 2871 .
- Baker , A M , Oberley , L W and Cohen , M B . 1997 . Expression of antioxidant enzymes in human prostatic adenocarcinoma . Prostate , 32 : 229 – 233 .
- Rosenblum , J S , Gilula , N B and Lerner , R A . 1996 . On signal sequence polymorphisms and diseases of distribution . Proc Natl Acad Sci U S A , 93 : 4471 – 4473 .
- Sutton , A , Khoury , H , Prip-Buus , C , Cepanec , C Pessayre , D . 2003 . The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria . Pharmacogenetics , 13 : 145 – 157 .
- Shimoda-Matsubayashi , S , Matsumine , H , Kobayashi , T , Nakagawa-Hattori , Y Shimizu , Y . 1996 . Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene: a predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease . Biochem Biophys Res Commun , 226 : 561 – 565 .
- Ambrosone , C B , Freudenheim , J L , Thompson , P A , Bowman , E Vena , J E . 1999 . Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer . Cancer Res , 59 : 602 – 606 .
- Mitrunen , K , Sillanpaa , P , Kataja , V , Eskelinen , M Kosma , V M . 2001 . Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk . Carcinogenesis , 22 : 827 – 829 .
- Tamimi , R M , Hankinson , S E , Spiegelman , D , Colditz , G A and Hunter , D J . 2004 . Manganese superoxide dismutase polymorphism, plasma antioxidants, cigarette smoking, and risk of breast cancer . Cancer Epidemiol Biomarkers Prev , 13 : 989 – 996 .
- Cai , Q , Shu , X O , Wen , W , Cheng , J R Dai , Q . 2004 . Genetic polymorphism in the manganese superoxide dismutase gene, antioxidant intake, and breast cancer risk: results from the Shanghai Breast Cancer Study . Breast Cancer Res , 6 : R647 – R655 .
- Hennekens , C H and Eberlein , K . 1985 . A randomized trial of aspirin and beta-carotene among U.S. physicians . Prev Med , 14 : 165 – 168 .
- Li , H , Kantoff , P W , Giovannucci , E , Leitzmann , M F Gaziano , J M . 2005 . Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer . Cancer Res , 65 : 2498 – 2504 .
- Lindahl , T and Wood , R D . 1999 . Quality control by DNA repair . Science , 286 : 1897 – 1905 .
- Dianov , G L , Prasad , R , Wilson , S H and Bohr , V A . 1999 . Role of DNA polymerase beta in the excision step of long patch mammalian base excision repair . J Biol Chem , 274 : 13741 – 13743 .
- Thompson , L H and West , M G . 2000 . XRCC1 keeps DNA from getting stranded . Mutat Res , 459 : 1 – 18 .
- Vidal , A E , Boiteux , S , Hickson , I D and Radicella , J P . 2001 . XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions . EMBO J , 20 : 6530 – 6539 .
- Tebbs , R S , Flannery , M L , Meneses , J J , Hartmann , A Tucker , J D . 1999 . Requirement for the Xrcc1 DNA base excision repair gene during early mouse development . Dev Biol , 208 : 513 – 529 .
- Shen , M R , Jones , I M and Mohrenweiser , H . 1998 . Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans . Cancer Res , 58 : 604 – 608 .
- Masson , M , Niedergang , C , Schreiber , V , Muller , S Menissier-de Murcia , J . 1998 . XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage . Mol Cell Biol , 18 : 3563 – 3571 .
- Goode , E L , Ulrich , C M and Potter , J D . 2002 . Polymorphisms in DNA repair genes and associations with cancer risk . Cancer Epidemiol Biomarkers Prev , 11 : 1513 – 1530 .
- Blazer , D G III , Umbach , D M , Bostick , R M and Taylor , J A . 2000 . Vitamin D receptor polymorphisms and prostate cancer . Mol Carcinog , 27 : 18 – 23 .
- van Gils , C H , Bostick , R M , Stern , M C and Taylor , J A . 2002 . Differences in base excision repair capacity may modulate the effect of dietary antioxidant intake on prostate cancer risk: an example of polymorphisms in the XRCC1 gene . Cancer Epidemiol Biomarkers Prev , 11 : 1279 – 1284 .
- Brenneman , M A , Weiss , A E , Nickoloff , J A and Chen , D J . 2000 . XRCC3 is required for efficient repair of chromosome breaks by homologous recombination . Mutat Res , 459 : 89 – 97 .
- Han , S , Zhang , H T , Wang , Z , Xie , Y Tang , R . 2006 . DNA repair gene XRCC3 polymorphisms and cancer risk: a meta-analysis of 48 case-control studies . Eur J Hum Genet , 14 : 1136 – 1144 .
- Ritchey , J D , Huang , W Y , Chokkalingam , A P , Gao , Y T Deng , J . 2005 . Genetic variants of DNA repair genes and prostate cancer: a population-based study . Cancer Epidemiol Biomarkers Prev , 14 : 1703 – 1709 .
- Soejima , H , Zhao , W and Mukai , T . 2005 . Epigenetic silencing of the MGMT gene in cancer . Biochem Cell Biol , 83 : 429 – 437 .
- Han , J , Tranah , G J , Hankinson , S E , Samson , L D and Hunter , D J . 2006 . Polymorphisms in O6-methylguanine DNA methyltransferase and breast cancer risk . Pharmacogenet Genomics , 16 : 469 – 474 .
- Glatt , H , Engelke , C E , Pabel , U , Teubner , W Jones , A L . 2000 . Sulfotransferases: genetics and role in toxicology . Toxicol Lett , 112–113 : 341 – 348 .
- Raunio , H , Husgafvel-Pursiainen , K , Anttila , S , Hietanen , E Hirvonen , A . 1995 . Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility—a review . Gene , 159 : 113 – 121 .
- Al-Buheissi , S Z , Patel , H R , Meinl , W , Hewer , A Bryan , R L . 2006 . N-Acetyltransferase and sulfotransferase activity in human prostate: potential for carcinogen activation . Pharmacogenet Genomics , 16 : 391 – 399 .
- Chou , H C , Lang , N P and Kadlubar , F F . 1995 . Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s) . Cancer Res , 55 : 525 – 529 .
- Raftogianis , R B , Wood , T C , Otterness , D M , Van Loon , J A and Weinshilboum , R M . 1997 . Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype . Biochem Biophys Res Commun , 239 : 298 – 304 .
- Seth , P , Lunetta , K L , Bell , D W , Gray , H Nasser , S M . 2000 . Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancer . Cancer Res , 60 : 6859 – 6863 .
- Wang , Y , Spitz , M R , Tsou , A M , Zhang , K Makan , N . 2002 . Sulfotransferase (SULT) 1A1 polymorphism as a predisposition factor for lung cancer: a case-control analysis . Lung Cancer , 35 : 137 – 142 .
- Bamber , D E , Fryer , A A , Strange , R C , Elder , J B Deakin , M . 2001 . Phenol sulphotransferase SULT1A1∗1 genotype is associated with reduced risk of colorectal cancer . Pharmacogenetics , 11 : 679 – 685 .
- Nowell , S , Ratnasinghe , D L , Ambrosone , C B , Williams , S Teague-Ross , T . 2004 . Association of SULT1A1 phenotype and genotype with prostate cancer risk in African-Americans and Caucasians . Cancer Epidemiol Biomarkers Prev , 13 : 270 – 276 .
- Murata , M , Watanabe , M , Yamanaka , M , Kubota , Y Ito , H . 2001 . Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population . Cancer Lett , 165 : 171 – 177 .
- Hayes , J D and Strange , R C . 1995 . Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress . Free Radic Res , 22 : 193 – 207 .
- McIlwain , C C , Townsend , D M and Tew , K D . 2006 . Glutathione S-transferase polymorphisms: cancer incidence and therapy . Oncogene , 25 : 1639 – 1648 .
- Brooks , J D , Weinstein , M , Lin , X , Sun , Y Pin , S S . 1998 . CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia . Cancer Epidemiol Biomarkers Prev , 7 : 531 – 536 .
- Rebbeck , T R . 1997 . Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility . Cancer Epidemiol Biomarkers Prev , 6 : 733 – 743 .
- Kelada , S N , Kardia , S L , Walker , A H , Wein , A J Malkowicz , S B . 2000 . The glutathione S-transferase-mu and -theta genotypes in the etiology of prostate cancer: genotype-environment interactions with smoking . Cancer Epidemiol Biomarkers Prev , 9 : 1329 – 1334 .
- Rebbeck , T R , Walker , A H , Jaffe , J M , White , D L Wein , A J . 1999 . Glutathione S-transferase-mu (GSTM1) and -theta (GSTT1) genotypes in the etiology of prostate cancer . Cancer Epidemiol Biomarkers Prev , 8 : 283 – 287 .
- Joseph , M A , Moysich , K B , Freudenheim , J L , Shields , P G Bowman , E D . 2004 . Cruciferous vegetables, genetic polymorphisms in glutathione S-transferases M1 and T1, and prostate cancer risk . Nutr Cancer , 50 : 206 – 213 .
- Chouinard , S , Pelletier , G , Belanger , A and Barbier , O . 2004 . Cellular specific expression of the androgen-conjugating enzymes UGT2B15 and UGT2B17 in the human prostate epithelium . Endocr Res , 30 : 717 – 725 .
- MacLeod , S L , Nowell , S , Plaxco , J and Lang , N P . 2000 . An allele-specific polymerase chain reaction method for the determination of the D85Y polymorphism in the human UDP-glucuronosyltransferase 2B15 gene in a case-control study of prostate cancer . Ann Surg Oncol , 7 : 777 – 782 .
- Hajdinjak , T and Zagradisnik , B . 2004 . Prostate cancer and polymorphism D85Y in gene for dihydrotestosterone degrading enzyme UGT2B15: frequency of DD homozygotes increases with Gleason Score . Prostate , 59 : 436 – 439 .
- Park , J , Chen , L , Shade , K , Lazarus , P Seigne , J . 2004 . Asp85tyr polymorphism in the udp-glucuronosyltransferase (UGT) 2B15 gene and the risk of prostate cancer . J Urol , 171 : 2484 – 2488 .
- Okugi , H , Nakazato , H , Matsui , H , Ohtake , N Nakata , S . 2006 . Association of the polymorphisms of genes involved in androgen metabolism and signaling pathways with familial prostate cancer risk in a Japanese population . Cancer Detect Prev , 30 : 262 – 268 .
- Park , J , Chen , L , Ratnashinge , L , Sellers , T A Tanner , J P . 2006 . Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men . Cancer Epidemiol Biomarkers Prev , 15 : 1473 – 1478 .
- Gsur , A , Preyer , M , Haidinger , G , Schatzl , G Madersbacher , S . 2002 . A polymorphism in the UDP-Glucuronosyltransferase 2B15 gene (D85Y) is not associated with prostate cancer risk . Cancer Epidemiol Biomarkers Prev , 11 : 497 – 498 .
- Moon , S J , Fryer , A A and Strange , R C . 2005 . Ultraviolet radiation, vitamin D and risk of prostate cancer and other diseases . Photochem Photobiol , 81 : 1252 – 1260 .
- Carlberg , C . 2003 . Current understanding of the function of the nuclear vitamin D receptor in response to its natural and synthetic ligands . Recent Results Cancer Res , 164 : 29 – 42 .
- Skowronski , R J , Peehl , D M and Feldman , D . 1995 . Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3 . Endocrinology , 136 : 20 – 26 .
- Morrison , N A , Qi , J C , Tokita , A , Kelly , P J Crofts , L . 1994 . Prediction of bone density from vitamin D receptor alleles . Nature , 367 : 284 – 287 .
- Colin , E M , Weel , A E , Uitterlinden , A G , Buurman , C J Birkenhager , J C . 2000 . Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1, 25-dihydroxyvitamin D3 . Clin Endocrinol (Oxf) , 52 : 211 – 216 .
- Berndt , S I , Dodson , J L , Huang , W Y and Nicodemus , K K . 2006 . A systematic review of vitamin D receptor gene polymorphisms and prostate cancer risk . J Urol , 175 : 1613 – 1623 .
- Li , H , Stampfer , M J , Hollis , J B , Mucci , L A Gaziano , J M . 2007 . A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer . PLoS Med , 4 : e103
- Ma , J , Stampfer , M J , Gann , P H , Hough , H L Giovannucci , E . 1998 . Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians . Cancer Epidemiol Biomarkers Prev , 7 : 385 – 390 .
- Zadshir , A , Tareen , N , Pan , D , Norris , K and Martins , D . 2005 . The prevalence of hypovitaminosis D among US adults: data from the NHANES III . Ethn Dis , 15 : S5–97 – 101 .
- Carpten , J , Nupponen , N , Isaacs , S , Sood , R Robbins , C . 2002 . Germline mutations in the ribonuclease L gene in families showing linkage with HPC1 . Nat Genet , 30 : 181 – 184 .
- Liu , X , Schumacher , F R , Plummer , S J , Jorgenson , E Casey , G . 2007 . Trans-fatty acid intake and increased risk of advanced prostate cancer: modification by RNASEL R462Q variant . Carcinogenesis , 28 : 1232 – 1236 .
- Mahmud , S , Franco , E and Aprikian , A . 2004 . Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis . Br J Cancer , 90 : 93 – 99 .
- MacLean , C H , Newberry , S J , Mojica , W A , Khanna , P Issa , A M . 2006 . Effects of omega-3 fatty acids on cancer risk: a systematic review . JAMA , 295 : 403 – 415 .
- Hedelin , M , Chang , E T , Wiklund , F , Bellocco , R Klint , A . 2007 . Association of frequent consumption of fatty fish with prostate cancer risk is modified by COX-2 polymorphism . Int J Cancer , 120 : 398 – 405 .
- deVere White , R W , Hackman , R M , Soares , S E , Beckett , L A Li , Y . 2004 . Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer . Urology , 63 : 259 – 263 .
- Hedelin , M , Balter , K A , Chang , E T , Bellocco , R Klint , A . 2006 . Dietary intake of phytoestrogens, estrogen receptor-beta polymorphisms and the risk of prostate cancer . Prostate , 66 : 1512 – 1520 .
- Wolff , T A and Wilson , J E . 2006 . Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility . Am Fam Physician , 74 : 1759 – 1760 .
- Lindor , N M , Petersen , G M , Hadley , D W , Kinney , A Y Miesfeldt , S . 2006 . Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review . JAMA , 296 : 1507 – 1517 .
- Mucci , L A , Wedren , S , Tamimi , R M , Trichopoulos , D and Adami , H O . 2001 . The role of gene-environment interaction in the aetiology of human cancer: examples from cancers of the large bowel, lung and breast . J Intern Med , 249 : 477 – 493 .
- Cook , N R , Le , I M , Manson , J E , Buring , J E and Hennekens , C H . 2000 . Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States) . Cancer Causes Control , 11 : 617 – 626 .
- Ergun , A , Lawrence , C A , Kohanski , M A , Brennan , T A and Collins , J J . 2007 . A network biology approach to prostate cancer . Mol Syst Biol , 3 : 82
- Semmes , O J , Malik , G and Ward , M . 2006 . Application of mass spectrometry to the discovery of biomarkers for detection of prostate cancer . J Cell Biochem , 98 : 496 – 503 .
- Dupuis , J and O'Donnell , C J . 2007 . Interpreting results of large-scale genetic association studies: separating gold from fool's gold . JAMA , 297 : 529 – 531 .
- http://www.ncbi.nlm.nih.gov/SNP/ Accessed August 24, 2007
- Marotta , F , Weksler , M , Naito , Y , Yoshida , C Yoshioka , M . 2006 . Nutraceutical supplementation: effect of a fermented papaya preparation on redox status and DNA damage in healthy elderly individuals and relationship with GSTM1 genotype: a randomized, placebo-controlled, cross-over study . Ann N Y Acad Sci , 1067 : 400 – 407 .